Keyphrases
Clinical Application
100%
Myelodysplastic Syndrome
100%
DNA Methyltransferase Inhibitor
100%
High-risk Myelodysplastic Syndrome
50%
Overall Survival
25%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
25%
Curative Treatment
25%
Heterogeneous Groups
25%
Treatment Options
25%
Therapeutic Potential
25%
Hematological Malignancies
25%
Acute Myeloid Leukemia
25%
Epigenetic Reprogramming
25%
Ineffective Hematopoiesis
25%
Peripheral Cytopenia
25%
Medicine and Dentistry
Myelodysplastic Syndrome
100%
DNA Methyltransferase Inhibitor
100%
Malignant Neoplasm
16%
Cytopenia
16%
Overall Survival
16%
Hematopoietic Stem Cell
16%
Acute Myeloid Leukemia
16%
Cell Transplantation
16%
Hematopoiesis
16%
Hematopoietic System Malignancy
16%
Pharmacology, Toxicology and Pharmaceutical Science
Myelodysplastic Syndrome
100%
DNA Methyltransferase Inhibitor
100%
Malignant Neoplasm
16%
Cytopenia
16%
Overall Survival
16%
Acute Myeloid Leukemia
16%
Hematopoietic System Malignancy
16%